U N S H A K E A B L E

PEPTALK · PEPTIDES UNPACKED

Built for the ones who don't slow down. Who expect a lot from their body.

Who are here to live better, longer.

GLP-1 and GIP: What They Actually Are — and Why Your Body Already Makes Them

You've heard of Ozempic. You've probably heard of Mounjaro. You may have even heard the terms GLP-1 and GIP thrown around in conversations about metabolism and weight loss. But here's what most of those conversations miss: these aren't pharmaceutical inventions. They're peptides your body already makes — every single time you eat.

Understanding what GLP-1 and GIP actually do — and why they matter far beyond the number on a scale — is one of the most important pieces of the metabolic health puzzle. Let's break it down in plain English.

The Shift From Calories to Communication

For decades, the dominant model of metabolism was simple: eat less, move more. Calories in, calories out. Weight management was framed as a math problem.

That model wasn't entirely wrong — but it was dramatically incomplete. What we now understand is that metabolism isn't just about energy balance. It's about communication. The body's ability to process food, store energy, regulate appetite, and maintain stable blood sugar depends on a complex messaging system — and GLP-1 and GIP are two of its most important messengers.

What Is GLP-1?

GLP-1 stands for glucagon-like peptide-1. The name is a mouthful, but the function is elegant. Every time you eat, your small intestine releases GLP-1 into the bloodstream. It then does several critical things simultaneously:

Think of GLP-1 as a highly coordinated traffic controller for your blood sugar — making sure glucose flows where it needs to go, at the right pace, without overwhelming the system.

What Is GIP?

GIP stands for glucose-dependent insulinotropic peptide — another mouthful that's much easier to understand in practice. GIP works as a partner to GLP-1, fine-tuning what insulin does in the body and playing a specific role in fat metabolism.

Where GLP-1 is the primary blood sugar manager, GIP steps in to help the body access fat stores for energy when blood sugar drops. It also supports how the liver handles excess glucose — which directly affects cholesterol levels and fatty liver risk.

Together, GLP-1 and GIP form the body's core metabolic messaging team. When they're working properly, blood sugar is stable, appetite is regulated, energy is consistent, and fat metabolism is efficient. When they're not — due to stress, poor sleep, inflammation, or years of metabolic strain — the whole system starts to break down.

The Grandfather Clock Analogy

Dr. Kylie Burton offers a useful way to visualize how these systems work together: imagine a grandfather clock, where you can see all the cogs and gears moving in unison. Every gear depends on the others. When one cog breaks or slows, the whole mechanism is affected.

The endocrine system works the same way. Reproductive hormones, thyroid hormones, cortisol, insulin, GLP-1, GIP — they're all gears in the same clock. When blood sugar signaling goes off, cortisol rises. When cortisol rises, thyroid function is suppressed. When thyroid function drops, metabolism slows. And so on.

This is why addressing GLP-1 and GIP signaling can have effects that ripple far beyond blood sugar — into hormone balance, energy, mood, inflammation, and brain function.

When the Signals Start to Fade

Your body produces GLP-1 and GIP naturally — but that production isn't guaranteed to stay robust. Chronic stress, poor sleep, gut inflammation, and years of blood sugar instability all degrade the signaling environment these peptides depend on.

When GLP-1 signaling fades, the pancreas doesn't get the message to release insulin efficiently. When GIP signaling drops, fat metabolism becomes less regulated and cholesterol levels can rise. The result is a body that's producing less of its own metabolic messengers — and becoming less responsive to the ones it does produce.

This is where peptide therapy enters the picture. GLP-1 and GIP receptor agonists — the class of medications that includes semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — work by mimicking and amplifying these natural signals. They don't replace the body's own production permanently. What they do is restore the signaling environment so the body can start hearing itself again.

Beyond Weight Loss: The Real Benefits

Weight change, when it happens with GLP-1 and GIP therapy, is largely a side effect of restored metabolic communication — not the primary mechanism. The deeper benefits include:

This is why Dr. Kylie Burton and Jessica Briecke consistently frame GLP-1 and GIP therapy as root-cause medicine — not a shortcut or a trend. Addressing the metabolic signaling system addresses the foundation that so many other symptoms rest on.

The bottom line

GLP-1 and GIP are not pharmaceutical inventions. They are natural, gut-produced peptides that your body has been using to regulate metabolism, appetite, and blood sugar your entire life. What peptide therapy does is restore and amplify that natural system when it has been compromised by age, lifestyle, or metabolic strain.

Here to help you become Unshakeable,

Dr. Kylie

This blog is based on Episode 5 of PepTalk: Peptides Unpacked, hosted by Dr. Kylie Burton and Jessica Briecke.

Learn more at drkylieburton.com

Legal Disclaimer: Every person's health journey is unique. The experiences shared here are real stories from real people working with medical professionals. Your results may differ. Peptide therapy is a prescription treatment that requires doctor supervision. We partner with a telemedicine company that provides access to licensed physicians to assist you in your peptide therapy journey.